FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2098771520> ?p ?o ?g. }

• W2098771520 endingPage "e63057" @default.
• W2098771520 startingPage "e63057" @default.
• W2098771520 abstract "Background Treatment-related outcomes in patients with extensively drug-resistant tuberculosis (XDR-TB) are poor. However, data about the type, frequency and severity of presumed drug-associated adverse events (AEs) and their association with treatment-related outcomes in patients with XDR-TB are scarce. Methods Case records of 115 South-African XDR-TB patients were retrospectively reviewed by a trained researcher. AEs were estimated and graded according to severity [grade 0 = none; grade 1–2 = mild to moderate; and grade 3–5 = severe (drug stopped, life-threatening or death)]. Findings 161 AEs were experienced by 67/115(58%) patients: 23/67(34%) required modification of treatment, the offending drug was discontinued in 19/67(28%), reactions were life-threatening in 2/67(3.0%), and 6/67(9.0%) died. ∼50% of the patients were still on treatment at the time of data capture. Sputum culture-conversion was less likely in those with severe (grade 3–5) vs. grade 0–2 AEs [2/27(7%) vs. 24/88(27%); p = 0.02]. The type, frequency and severity of AEs was similar in HIV-infected and uninfected patients. Capreomycin, which was empirically administered in most cases, was withdrawn in 14/104(14%) patients, implicated in (14/34) 41% of the total drug withdrawals, and was associated with all 6 deaths in the severe AE group (renal failure in five patients and hypokalemia in one patient). Conclusion Drug-associated AEs occur commonly with XDR-TB treatment, are often severe, frequently interrupt therapy, and negatively impact on culture conversion outcomes. These preliminary data inform on the need for standardised strategies (including pre-treatment counselling, early detection, monitoring, and follow-up) and less toxic drugs to optimally manage patients with XDR-TB." @default.
• W2098771520 created "2016-06-24" @default.
• W2098771520 creator A5012246644 @default.
• W2098771520 creator A5020538858 @default.
• W2098771520 creator A5021801489 @default.
• W2098771520 creator A5024726181 @default.
• W2098771520 creator A5026225819 @default.
• W2098771520 creator A5031509709 @default.
• W2098771520 creator A5034975443 @default.
• W2098771520 creator A5036770578 @default.
• W2098771520 creator A5042190598 @default.
• W2098771520 creator A5056139536 @default.
• W2098771520 creator A5059371295 @default.
• W2098771520 creator A5062490980 @default.
• W2098771520 creator A5076985630 @default.
• W2098771520 creator A5077397137 @default.
• W2098771520 creator A5083781913 @default.
• W2098771520 date "2013-05-07" @default.
• W2098771520 modified "2023-09-28" @default.
• W2098771520 title "Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa" @default.
• W2098771520 cites W2023453201 @default.
• W2098771520 cites W2089780776 @default.
• W2098771520 cites W2097132672 @default.
• W2098771520 cites W2103230556 @default.
• W2098771520 cites W2108606970 @default.
• W2098771520 cites W2117810067 @default.
• W2098771520 cites W2134558351 @default.
• W2098771520 cites W2136694704 @default.
• W2098771520 cites W2140154490 @default.
• W2098771520 cites W2140828933 @default.
• W2098771520 cites W2161118379 @default.
• W2098771520 doi "https://doi.org/10.1371/journal.pone.0063057" @default.
• W2098771520 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3669431" @default.
• W2098771520 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23667572" @default.
• W2098771520 hasPublicationYear "2013" @default.
• W2098771520 type Work @default.
• W2098771520 sameAs 2098771520 @default.
• W2098771520 citedByCount "71" @default.
• W2098771520 countsByYear W20987715202013 @default.
• W2098771520 countsByYear W20987715202014 @default.
• W2098771520 countsByYear W20987715202015 @default.
• W2098771520 countsByYear W20987715202016 @default.
• W2098771520 countsByYear W20987715202017 @default.
• W2098771520 countsByYear W20987715202018 @default.
• W2098771520 countsByYear W20987715202019 @default.
• W2098771520 countsByYear W20987715202020 @default.
• W2098771520 countsByYear W20987715202021 @default.
• W2098771520 countsByYear W20987715202022 @default.
• W2098771520 countsByYear W20987715202023 @default.
• W2098771520 crossrefType "journal-article" @default.
• W2098771520 hasAuthorship W2098771520A5012246644 @default.
• W2098771520 hasAuthorship W2098771520A5020538858 @default.
• W2098771520 hasAuthorship W2098771520A5021801489 @default.
• W2098771520 hasAuthorship W2098771520A5024726181 @default.
• W2098771520 hasAuthorship W2098771520A5026225819 @default.
• W2098771520 hasAuthorship W2098771520A5031509709 @default.
• W2098771520 hasAuthorship W2098771520A5034975443 @default.
• W2098771520 hasAuthorship W2098771520A5036770578 @default.
• W2098771520 hasAuthorship W2098771520A5042190598 @default.
• W2098771520 hasAuthorship W2098771520A5056139536 @default.
• W2098771520 hasAuthorship W2098771520A5059371295 @default.
• W2098771520 hasAuthorship W2098771520A5062490980 @default.
• W2098771520 hasAuthorship W2098771520A5076985630 @default.
• W2098771520 hasAuthorship W2098771520A5077397137 @default.
• W2098771520 hasAuthorship W2098771520A5083781913 @default.
• W2098771520 hasBestOaLocation W20987715201 @default.
• W2098771520 hasConcept C126322002 @default.
• W2098771520 hasConcept C142724271 @default.
• W2098771520 hasConcept C167135981 @default.
• W2098771520 hasConcept C197934379 @default.
• W2098771520 hasConcept C2776228421 @default.
• W2098771520 hasConcept C2776301714 @default.
• W2098771520 hasConcept C2777025531 @default.
• W2098771520 hasConcept C2777107064 @default.
• W2098771520 hasConcept C2777768864 @default.
• W2098771520 hasConcept C2777975735 @default.
• W2098771520 hasConcept C2778242168 @default.
• W2098771520 hasConcept C2779912665 @default.
• W2098771520 hasConcept C2780035454 @default.
• W2098771520 hasConcept C2781019175 @default.
• W2098771520 hasConcept C2781069245 @default.
• W2098771520 hasConcept C500440147 @default.
• W2098771520 hasConcept C71924100 @default.
• W2098771520 hasConcept C98274493 @default.
• W2098771520 hasConceptScore W2098771520C126322002 @default.
• W2098771520 hasConceptScore W2098771520C142724271 @default.
• W2098771520 hasConceptScore W2098771520C167135981 @default.
• W2098771520 hasConceptScore W2098771520C197934379 @default.
• W2098771520 hasConceptScore W2098771520C2776228421 @default.
• W2098771520 hasConceptScore W2098771520C2776301714 @default.
• W2098771520 hasConceptScore W2098771520C2777025531 @default.
• W2098771520 hasConceptScore W2098771520C2777107064 @default.
• W2098771520 hasConceptScore W2098771520C2777768864 @default.
• W2098771520 hasConceptScore W2098771520C2777975735 @default.
• W2098771520 hasConceptScore W2098771520C2778242168 @default.
• W2098771520 hasConceptScore W2098771520C2779912665 @default.
• W2098771520 hasConceptScore W2098771520C2780035454 @default.
• W2098771520 hasConceptScore W2098771520C2781019175 @default.

• next